Toxicity of High-Dose Ara-C Postremission Therapy in CCG-2891
| Grade III or IV Toxicity . | DS . | No DS . | P Value . | ||
|---|---|---|---|---|---|
| n = 68 . | (%) . | n = 236 . | (%) . | ||
| Liver | 2 | (3) | 11 | (5) | .78 |
| Gastrointestinal | 6 | (9) | 14 | (6) | .57 |
| CNS | 1 | (2) | 4 | (2) | .68 |
| Death | 1 | (2) | 12 | (5) | .34 |
| Median duration in days | 43 | 45 | |||
| Grade III or IV Toxicity . | DS . | No DS . | P Value . | ||
|---|---|---|---|---|---|
| n = 68 . | (%) . | n = 236 . | (%) . | ||
| Liver | 2 | (3) | 11 | (5) | .78 |
| Gastrointestinal | 6 | (9) | 14 | (6) | .57 |
| CNS | 1 | (2) | 4 | (2) | .68 |
| Death | 1 | (2) | 12 | (5) | .34 |
| Median duration in days | 43 | 45 | |||